Chief Commercial Officer @ (February 2023 - January 2026)
Chief Marketing Officer @ (September 2019 - January 2023)
Vice President Sales and Marketing @ (November 2017 - August 2019)
Head, Health Solutions Business Unit @ (October 2016 - October 2017)
Vice President, Head of North America Marketing @ (October 2014 - October 2016)
Vice President, Marketing--Mylan Pharmaceuticals and Mylan Institutional (Injectables) @ (January 2013 - October 2014)
Marketing Leadership @ (January 2012 - January 2013)
Sales and Marketing Leadership and Product and Portfolio Marketing and Sales Ops @ (January 1997 - January 2012)
Michael Scouvart Education
The Ohio State University - The Max M. Fisher College of Business
MBA
2001-2003
California University of Pennsylvania
Bachelor of Science - BS (NCAA Division II Baseball Scholarship—Captain)
Michael Scouvart Skills
Pharmaceutical Industry
Pharmaceutical Sales
Marketing Strategy
Oncology
Product Launch
Sales Effectiveness
Cross-functional Team Leadership
Sales Operations
Market Analysis
Urology
Sales Management
Hospital Sales
Neurology
Rheumatology
Gastroenterology
Strategic Planning
Managed Care
Healthcare
Business Development
Market Access
Business Planning
Forecasting
Diabetes
Managed Markets
Infectious Diseases
Medical Affairs
Vaccines
Team Leadership
Customer Service
Strategy
Cross Functional Team Leadership
Cross Functional Team
Leadership
Team Building
Michael Scouvart Summary
Michael Scouvart, based in United States, is currently a Senior Vice President, Commercial at Harrow. Michael Scouvart brings experience from previous roles at SCOVE Commercial and QuVa Pharma, Inc.. Michael Scouvart holds a 2001 - 2003 MBA @ The Ohio State University - The Max M. Fisher College of Business. With a robust skill set that includes Pharmaceutical Industry, Pharmaceutical Sales, Marketing Strategy, Oncology, Product Launch and more. Michael Scouvart has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Scouvart?
Find contact details for 700 million professionals.